Document is current
Any future updates will be listed below
-
Authors
Barbakoff, Daniel https://orcid.org/0009-0002-6608-0245
Wald, Gal https://orcid.org/0000-0001-6438-0872
Strasser, Mary Oakley
Yu, Rebecca
Winograd, Joshua https://orcid.org/0000-0002-7386-4323
Huang, Mitchell
Driscoll, Conor B. https://orcid.org/0000-0001-7730-6145
Handa, Nicole https://orcid.org/0000-0002-0700-7200
Vickers, Andrew
Schaeffer, Edward M. https://orcid.org/0000-0003-0699-1899
Hu, Jim C.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (P30-CA008748)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01 CA241758)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (P30-CA008748)
Patient-Centered Outcomes Research Institute (CER-2019C2-17372)
- License Information
-
More Information
Article History
Received: 23 June 2025
Revised: 18 February 2026
Accepted: 16 March 2026
First Online: 27 April 2026
Competing interests
: The authors declare no competing interests.
: All methods were performed in accordance with the relevant guidelines and regulations of the Declaration of Helsinki. Ethical approval for this study was obtained from the IRB of the Biomedical Research Alliance of New York (protocol number #18-02-365). Informed consent was obtained from all participants within this study.
